Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs
Recent Alliance Targets Malaria’s Achilles’ Heel: The Parasite’s Skeleton A groundbreaking research collaboration between the Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc. Promises a fresh approach to combating malaria. Supported by the Gates Foundation, the partnership focuses on disrupting the Plasmodium parasite’s cytoskeleton – a strategy that could unlock a new … Read more